A controlled ,Prospective Study of the Effects of statins on Progression of diabetic nephropathy
Not Applicable
- Conditions
- diabetic nephropathy
- Registration Number
- JPRN-UMIN000001724
- Lead Sponsor
- Fukuiken-Saiseikai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1 While person take statins, or statins administration is done one within three months 2 160/100mm Hg is more than most recent twice sphygmomanometry value together the one where blood pressure control is poor 3 Drifting for three months is higher than 2% more than most recent HbA1c10% recently the one where glycemic control states are defectiveness or insecurity 4 The one that presents nephrotic syndrome 5 The person who judged that others, a family doctor were inadequate 6 Others, Dr.clinical study liability or Dr.clinical study allotment is this clinical study which they intend for it and judged to be inadequate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prospective Study of the Effects of Cholesterol-lowering therapy in Between 3 group ( diet therapy group, standard therapies group (pravastatin 10mg), iactive treatment group(atorvastatin10mg )on Progression of diabetic nephropathy.
- Secondary Outcome Measures
Name Time Method 1)Nephropathic analysis in before and after about chemical administration 2)Analysis of LDL-C in before and after about this chemical administration 3)Comparison in diet therapy,atorvastatin,pravastatin in superscription